中文名 | 2-氰基-3-吗啉丙酰胺 |
---|---|
英文名 | 2-Cyano-3-morpholinoacrylamide |
中文别名 | 2-氰基-3-吗啉丙烯酰胺 |
英文别名 |
2-Cyano-3-(4-morpholinyl)propenamide
2-Cyano-3-morpholin-4-ylprop-2-enamide 3-Morpholino-2-cyanacrylamid 3-Morpholino-2-cyanoacrylamide 2-cyano-3-morpholin-4-yl-acrylamide 3-MORPHOLINE-2-CYANOACYLAMIDE 2-Propenamide,2-cyano-3-(4-morpholinyl) |
密度 | 1.342g/cm3 |
---|---|
沸点 | 396.1ºC at 760mmHg |
熔点 | 173-177ºC |
分子式 | C8H11N3O2 |
分子量 | 181.19200 |
闪点 | 193.4ºC |
精确质量 | 181.08500 |
PSA | 79.35000 |
外观性状 | 淡黄色结晶粉末 |
蒸汽压 | 1.75E-06mmHg at 25°C |
折射率 | 1.618 |
储存条件 | 放入紧密的贮藏器内,储存在阴凉,干燥的地方 |
稳定性 | 避免接触强氧化物,酸,酸酸酐,酸性氯化物 |
分子结构 | 1、 摩尔折射率:47.31 2、 摩尔体积(m3/mol):134.9 3、 等张比容(90.2K):395.6 4、 表面张力(dyne/cm):73.9 5、 极化率(10-24cm3):18.75 |
计算化学 | 1、 疏水参数计算参考值(XlogP):-0.4 2、 氢键供体数量:1 3、 氢键受体数量:4 4、 可旋转化学键数量:2 5、 互变异构体数量:2 6、 拓扑分子极性表面积(TPSA):79.4 7、 重原子数:13 8、 表面电荷:0 9、 复杂度:270 10、 同位素原子数量:0 11、 确定原子立构中心数量:0 12、 不确定原子立构中心数量:0 13、 确定化学键立构中心数量:0 14、 不确定化学键立构中心数量:1 15、 共价键单元数量:1 |
更多 | 1. 性状:未确定 2. 密度(g/mL,25/4℃):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):173-177 5. 沸点(ºC,常压):未确定 6. 沸点(ºC,5.2kPa):未确定 7. 折射率:未确定 8. 闪点(ºC):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(kpa,20ºC):未确定 12. 饱和蒸气压(kPa,60ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:未确定 |
Synonym: Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: 36/37/38 Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin. Potential Health Effects Eye: Causes eye irritation. Skin: Causes skin irritation. May be harmful if absorbed through the skin. Ingestion: May cause irritation of the digestive tract. May be harmful if swallowed. Inhalation: Causes respiratory tract irritation. May be harmful if inhaled. May cause burning sensation, coughing, wheezing, laryngitis, shortness of breath, headache, nausea, and vomiting. Chronic: Not available. Section 4 - FIRST AID MEASURES Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Ingestion: Get medical aid. Wash mouth out with water. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Treat symptomatically and supportively. Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Extinguishing Media: Use foam, dry chemical, or carbon dioxide. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Section 7 - HANDLING and STORAGE Handling: Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Use only in a chemical fume hood. Storage: Store in a cool, dry place. Store in a tightly closed container. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 25229-97-4: Personal Protective Equipment Eyes: Not available. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Liquid Color: Not available. Odor: Not available. pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: 173-175 deg C Autoignition Temperature: Not available. Flash Point: Not available. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Solubility in water: Specific Gravity/Density: Molecular Formula: C8H11N3O2 Molecular Weight: 181.0959 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Not available. Conditions to Avoid: Incompatible materials. Incompatibilities with Other Materials: Strong oxidizing agents, acids, acid chlorides, carbon dioxide, acid anhydrides. Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, carbon dioxide. Hazardous Polymerization: Has not been reported Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 25229-97-4 unlisted. LD50/LC50: Not available. Carcinogenicity: 2-Cyano-3-morpholinoacrylamide - Not listed by ACGIH, IARC, or NTP. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA No information available. IMO No information available. RID/ADR No information available. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: XI Risk Phrases: R 36/37/38 Irritating to eyes, respiratory system and skin. Safety Phrases: S 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S 37/39 Wear suitable gloves and eye/face protection. WGK (Water Danger/Protection) CAS# 25229-97-4: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 25229-97-4 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 25229-97-4 is not listed on the TSCA inventory. It is for research and development use only. SECTION 16 - ADDITIONAL INFORMATION N/A |
危害码 (欧洲) | Xi: Irritant; |
---|---|
风险声明 (欧洲) | R36/37/38 |
安全声明 (欧洲) | S26-S37/39 |
上游产品 2 | |
---|---|
下游产品 0 |